Creating Cures Through Facility Investments

In 2019, we invested nearly $1 billion in new and existing facilities to fulfill our commitment to deliver breakthroughs that change patients' lives. Our latest investments include:

• An expansion of our manufacturing facility in Sanford, North Carolina, including a new facility for producing and supplying critical, potentially life-changing gene therapies to patients living with rare diseases around the world.
• A new, state-of-the-art research and development facility in Chesterfield, Missouri, dedicated to discovering new biologic therapies and vaccines.
• A new manufacturing facility at our Andover, Massachussetts, campus that produces advanced clinical supplies and accelerates the development of important treatments for patients.